Klaus Wellner

Title: Klaus Wellner: Innovator in Hematology

Introduction

Klaus Wellner is a notable inventor based in Marburg, Germany. He has made significant contributions to the field of hematology, particularly in the development of treatments related to von Willebrand factor and factor VIII.

Latest Patents

Wellner holds two patents that showcase his innovative work. The first patent is for a pasteurized, purified von Willebrand factor concentrate and a process for its preparation. This process involves creating a concentrate of von Willebrand factor in a solution with factor VIII:C, which can be pasteurized and treated with an anion exchanger without binding the von Willebrand factor. The second patent details a process for the preparation of a stable factor VIII concentrate. This process includes adsorbing impurities from the factor VIII solution through at least two-fold adsorption using Al(OH)₃, an anion exchanger, or Ca₃(PO₄)₂, preferably with two different adsorbents from this group.

Career Highlights

Throughout his career, Klaus Wellner has worked with prominent companies in the biopharmaceutical industry. He has been associated with Behringwerke Aktiengesellschaft and Aventis Behring GmbH, where he contributed to advancements in blood factor therapies.

Collaborations

Wellner has collaborated with esteemed colleagues, including Norbert Heimburger and Karl-Heinz Wenz, further enhancing his contributions to the field.

Conclusion

Klaus Wellner's innovative patents and career in hematology reflect his dedication to improving treatments for blood disorders. His work continues to impact the medical community positively.